6Stephanie SP, Silvani V, Cleide RWV, et al. Influence of mi- croencapsulation with sweet whey and prebioties on the surviv- al of Bifidobacterium-BB-12 under simulated gastrointestinal conditions and heat treatments [J]. Lwt-Food Sci N- Technol, 2015, 64(2): 1004-1009.
7Oliveira de, Cybelle Pereira, Silva da, et ai. Nature of the an- timierobial activity of Lactobacillus casei , Bi fidobacterium bi fidum and Bi fidobacterium animalis against {oodborne pathogenic and spoilage microorganisms J. Natl Product Res, 2015, 29(22): 2133-2136.
8Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to beta-Lactamase Klebsiella pneurnoniae Carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes[J]. Clin Infect Dis, 2010, 50(3): 364-373.
9CLSI. Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition. CLSI document M02-A10[S]. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
10Liao CH, Kung HC, Hsu GJ, et al. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods[J]. Int J Antimicrob Agents, 2008, 32 (Suppl 3): S192-S196.
